-
Melatonin Fails to Ease Fatigue in Patients With Early-Stage Breast Cancer Undergoing Radiotherapy
24 Apr 2024 17:34 GMT
… in patients with early-stage breast cancer undergoing radiotherapy (RT) treatment, … 2
Early-stage breast cancer is classified as ductal carcinoma in situ and stage … oxidative damage to mitochondria.1
Breast cancer treatment typically involves radiation …
-
Early Breast-Cancer Diagnosis? Do This Next
23 Apr 2024 01:07 GMT
… also considered ductal carcinoma in situ (when cells lining the … an oncologist or a breast-cancer surgeon, consider writing down … for someone who approaches breast cancer holistically: “A lot … to control an early breast-cancer diagnosis and everything that …
-
7-Gene Predictive Biosignature Helps Predict Ipsilateral Breast Cancer Recurrence
22 Apr 2024 22:30 GMT
Patients with breast cancer who have a high- … for patients with ductal carcinoma in situ (DCIS), there is increasing … given the greater than 95% breast cancer-specific survival rates, and … for patients with ductal carcinoma in situ designed to predict RT …
-
‘Magic Mike’ actress details ‘terrifying’ breast cancer diagnosis, 4 surgeries in 10 months, and medically induced menopause
21 Apr 2024 11:24 GMT
… was diagnosed with bilateral breast cancer after tests revealed she … of five types of breast cancer are discovered through mammograms … decided to calculate her Breast Cancer Risk Assessment Score. The … section of ductal carcinoma in situ, a preinvasive cancer, …
-
Kintara Therapeutics : TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - Form 8-K
25 Apr 2024 13:10 GMT
… IFx-Hu2.0, a novel in situ cancer vaccine, in checkpoint inhibitor … -001 Therapy for cutaneous metastatic breast cancer ("CMBC").
Kintara has …
-
Promising perspectives for the application of SDS Optic’s inPROBE technology platform for protein expression determination
25 Apr 2024 12:00 GMT
… such as immunohistochemistry and fluorescence in situ hybridization depend on subjective assessment … inPROBE®. The study involved 22 breast cancer patients, with 18 completing the … Clinical Landscape of HER2-Low Breast Cancer. Cancers 2023, 15, 126. Media …
-
Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations
25 Apr 2024 08:08 GMT
… . Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel … of chemotherapeutics to triple negative breast cancer cells and spheroids. Pharm Res … therapeutic index of doxorubicin for breast cancer. Eur Polym J. 2019;116 …
-
Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma
25 Apr 2024 07:08 GMT
… a simple FISH test (fluorescence in situ hybridization) that is specific for … carcinoma, e.g. lung and breast cancer. The consideration of NECTIN4 amplification …
-
Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinoma
24 Apr 2024 21:42 GMT
… a simple FISH test (fluorescence in situ hybridization) that is specific for … carcinoma, e.g. lung and breast cancer. The consideration of NECTIN4 amplification …
-
The Operative Word
24 Apr 2024 17:13 GMT
… PB-IORT has an acceptable breast cancer recurrence rate, minimal side effects … Cost Implications of Commercially Available Noninvasive Colorectal Cancer Screening Modalities
In … the fecal immunochemical test for noninvasive colorectal cancer screening could …